5/23/2022 | HY | Market Commentary: Morning Commentary: Junk opens week stronger; athenahealth, Medline bonds trade higher
|
3/9/2022 | BKCVDDEMIGPV | Market Commentary: Carpenter on deck; risk-on in junk secondary; Carnival, American pare losses; Athena better
|
3/9/2022 | HY | Market Commentary: Carpenter on deck; risk-on in junk secondary; Carnival, American pare losses; Athena better
|
2/10/2022 | HY | Market Commentary: NCL prices in choppy waters; secondary falls on CPI report; short-term notes ‘get socked’
|
2/9/2022 | BKCVDDEMIGPV | Market Commentary: Studio City brings new paper; secondary junk improves but BWICs abound ahead of CPI report
|
2/9/2022 | HY | Market Commentary: Studio City brings new paper; secondary junk improves but BWICs abound ahead of CPI report
|
2/8/2022 | BKCVDDEMIGPV | Market Commentary: News Corp. shows up in junkland; McAfee, athenahealth improve; Wesco gives back gains
|
2/8/2022 | HY | Market Commentary: News Corp. shows up in junkland; McAfee, athenahealth improve; Wesco gives back gains
|
2/7/2022 | HY | Market Commentary: Crescent Energy adds on; McAfee losses mount; Wesco gains; Spirit Airlines up on acquisition
|
2/1/2022 | BKCVDDEMIGPV | Market Commentary: February junk primary kicks off with add-on; Athena breaks par; Pitney Bowes under pressure
|
2/1/2022 | HY | Market Commentary: February junk primary kicks off with add-on; Athena breaks par; Pitney Bowes under pressure
|
1/31/2022 | BKCVDDEMIGPV | Market Commentary: Calendar builds; secondary firms; Bausch, Embecta improve
|
1/31/2022 | HY | Market Commentary: Calendar builds; secondary firms; Bausch, Embecta improve; Athena struggles continue
|
1/28/2022 | BKCVDDEMIGPV | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
1/28/2022 | HY | Market Commentary: ION, Covis on hold; volatile junk market ends day up, week down; athenahealth struggles
|
1/27/2022 | HY | Market Commentary: Junk primary has biggest session year to date; secondary trading ‘ugly’ as selling accelerates
|
1/27/2022 | HY | New Issue: athenahealth prices downsized $2.35 billion eight-year notes at par to yield 6˝%
|
1/27/2022 | HY | athenahealth talks downsized $2.35 billion eight-year senior notes at 6˝% area; pricing Thursday
|
1/26/2022 | HY | athenahealth downsizes bond deal to $2.35 billion; eight-year notes to price Thursday
|
1/25/2022 | HY | Market Commentary: ION on tap; junk secondary weaker; Oxford outperforms; Medline gains; Netflix active
|
1/24/2022 | HY | Market Commentary: Oxford prices; wild ride in junk secondary; VistaJet, CHS drop par; Fertitta down
|
1/24/2022 | HY | athenahealth/Minerva marketing $2.5 billion eight-year senior notes; talk low-to-mid 6% area
|